Business

Missouri Judge Approves Bayer’s $7.25 Billion Roundup Settlement

A Missouri state judge has approved a multibillion-dollar settlement to resolve the vast majority of ongoing Roundup-related cancer lawsuits in the United States.

A Missouri state judge on Nov. 20 approved a $7.25 billion settlement regarding lawsuits that allege the weedkiller Roundup causes cancer. The decision marks a significant development in a legal battle that has persisted for nearly a decade and weighed heavily on the German conglomerate Bayer.

Judge Timothy Boyer of a state court in St. Louis ruled that the settlement agreement was “fair, reasonable, and adequate.” During the proceedings, the court overruled objections raised by some claimants who argued that the payouts offered to individual cancer victims were insufficient, noting that previous claimants had received larger settlements. Addressing these concerns, Judge Boyer emphasized that delaying the payouts could force victims, including those with terminal cancer, to endure an “indeterminate number of years” waiting to receive compensation.

The settlement, which was initially announced in February, is designed to resolve nearly all current and future Roundup claims in the United States. Bayer has been managing approximately 65,000 claims across U.S. state and federal courts from individuals who allege they developed cancer after utilizing the weedkiller in both professional and residential settings.

Bayer CEO Bill Anderson described the court’s final approval as a “decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation.” Since acquiring the manufacturer of Roundup, Monsanto, in 2018 for $63 billion, Bayer has faced extensive litigation that contributed to a 46% decline in its share price. The company previously settled much of the litigation for $10.9 billion in 2020 but had struggled to gain court approval for a subsequent $1.25 billion settlement intended to resolve future claims.

Throughout the litigation, Bayer has maintained that Roundup and its active ingredient, glyphosate, are safe, citing decades of scientific research. The recent judicial approval follows a shift in the legal landscape regarding these cases. Five months prior to the judge’s decision, the U.S. Supreme Court overturned a $1.25 million jury award for a Missouri man, John Durnell, who claimed that his years of exposure to glyphosate caused his non-Hodgkin lymphoma. In a 7-2 ruling, the Supreme Court sided with Bayer, determining that federal law regulating pesticides barred failure-to-warn claims brought under state law. This decision undercut a key pillar of many of the lawsuits against the company.

Christopher Seeger, a lawyer representing many of the plaintiffs, acknowledged that the Supreme Court’s decision in the Durnell case constrained the ability of victims to pursue certain claims in court. Regarding the approved settlement, Seeger stated, “We look forward to getting this relief into the hands of all Roundup victims as quickly as possible.”

Despite this settlement approval, the legal process is not entirely concluded. The agreement excludes some lawsuits that remain pending in federal court. Bayer reports that approximately 200 of those cases are still being litigated, and the company maintains that the Supreme Court’s ruling has provided it with strong defenses against them.

Mia Reynolds

Mia Reynolds covers companies, entrepreneurship, leadership, and changing industries. She turns complex business developments into accessible stories, helping readers follow corporate decisions, market shifts, and trends influencing the global business landscape.
Back to top button